303 related articles for article (PubMed ID: 29709947)
1. A Punctate Magnetic Resonance Imaging Pattern in a Patient with Systemic Lupus Erythematosus Is an Early Sign of Progressive Multifocal Leukoencephalopathy: A Clinicopathological Study.
Ishii J; Shishido-Hara Y; Kawamoto M; Fujiwara S; Imai Y; Nakamichi K; Kohara N
Intern Med; 2018 Sep; 57(18):2727-2734. PubMed ID: 29709947
[TBL] [Abstract][Full Text] [Related]
2. Punctate pattern: A promising imaging marker for the diagnosis of natalizumab-associated PML.
Hodel J; Darchis C; Outteryck O; Verclytte S; Deramecourt V; Lacour A; Zins M; Pruvo JP; Vermersch P; Leclerc X
Neurology; 2016 Apr; 86(16):1516-23. PubMed ID: 27009257
[TBL] [Abstract][Full Text] [Related]
3. Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus.
Beppu M; Kawamoto M; Nukuzuma S; Kohara N
Intern Med; 2012; 51(10):1245-7. PubMed ID: 22687798
[TBL] [Abstract][Full Text] [Related]
4. Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus.
Ahmed F; Aziz T; Kaufman LD
J Rheumatol; 1999 Jul; 26(7):1609-12. PubMed ID: 10405953
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Cerebellar PML with a CD4/CD8 Ratio of 2.9 Showed a Favorable Prognosis in a Patient with Rheumatoid Arthritis.
Nishigori R; Warabi Y; Shishido-Hara Y; Nakamichi K; Nakata Y; Komori T; Isozaki E
Intern Med; 2019 Nov; 58(22):3323-3329. PubMed ID: 31366796
[TBL] [Abstract][Full Text] [Related]
6. Pomalidomide-associated progressive multifocal leukoencephalopathy in multiple myeloma: cortical susceptibility-weighted imaging hypointense findings prior to clinical deterioration.
Ueno H; Kikumto M; Takebayashi Y; Ishibashi H; Takahashi T; Yasutomi H; Umemoto K; Nakamichi K; Saijo M; Ichinohe T; Maruyama H
J Neurovirol; 2020 Jun; 26(3):452-455. PubMed ID: 32394398
[TBL] [Abstract][Full Text] [Related]
7. The 'across the pons' sign: A possible novel radiographic finding in natalizumab-associated progressive multifocal leukoencephalopathy.
Budhram A; Pelikan JB; Kremenchutzky M; Sharma M
J Neurol Sci; 2017 Apr; 375():304-306. PubMed ID: 28320156
[No Abstract] [Full Text] [Related]
8. [Two patients with progressive multifocal leukoencephalopathy with immune response against JC virus showing good long-term outcome by combination therapy of mefloquine, mirtazapine, and risperidone].
Akagawa Y; Ueno A; Ikeda J; Ishii W; Shishido-Hara Y; Sekijima Y
Rinsho Shinkeigaku; 2018 May; 58(5):324-331. PubMed ID: 29710027
[TBL] [Abstract][Full Text] [Related]
9. MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance.
Wijburg MT; Witte BI; Vennegoor A; Roosendaal SD; Sanchez E; Liu Y; Martins Jarnalo CO; Uitdehaag BM; Barkhof F; Killestein J; Wattjes MP
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1138-45. PubMed ID: 27530808
[TBL] [Abstract][Full Text] [Related]
10. Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).
Schneider R; Bellenberg B; Hoepner R; Kolb EM; Ellrichmann G; Haghikia A; Gold R; Lukas C
PLoS One; 2017; 12(4):e0176415. PubMed ID: 28445498
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of non-HIV progressive multifocal leukoencephalopathy: case report and literature review.
Hamaguchi M; Suzuki K; Fujita H; Uzuka T; Matsuda H; Shishido-Hara Y; Arai S; Nakamura T; Kikuchi S; Nakamichi K; Saijo M; Hirata K
J Neurol; 2020 Mar; 267(3):731-738. PubMed ID: 31728711
[TBL] [Abstract][Full Text] [Related]
12. [A case of progressive multifocal leukoencephalopathy presenting white matter MRI lesions extending over the cerebral cortex and a marked decrease in cerebral blood flow on SPECT, and associated with HTLV-I infection].
Takase K; Ohyagi Y; Furuya H; Nagashima K; Taniwaki T; Kira J
Rinsho Shinkeigaku; 2005 Jun; 45(6):426-30. PubMed ID: 16022467
[TBL] [Abstract][Full Text] [Related]
13. Progressive multifocal leukoencephalopathy associated with mycophenolate mofetil treatment in a woman with lupus and CD4+ T-lymphocyte deficiency.
Pavlovic AM; Bonaci-Nikolic B; Kozic D; Ostojic J; Abinun M; Svabic-Medjedovic T; Nikolic M; Sternic N
Lupus; 2012 Jan; 21(1):100-2. PubMed ID: 21976399
[TBL] [Abstract][Full Text] [Related]
14. Asymptomatic progressive multifocal leukoencephalopathy during natalizumab therapy with treatment.
Fabis-Pedrini MJ; Xu W; Burton J; Carroll WM; Kermode AG
J Clin Neurosci; 2016 Mar; 25():145-7. PubMed ID: 26541323
[TBL] [Abstract][Full Text] [Related]
15. A Chronic Lymphocytic Leukemia Patient with Progressive Multifocal Leukoencephalopathy Caused by John Cunningham Virus.
Ramadhani P; Bramantono B; Sedana MP
Acta Med Indones; 2018 Apr; 50(2):151-158. PubMed ID: 29950535
[TBL] [Abstract][Full Text] [Related]
16. Asymptomatic progressive multifocal leukoencephalopathy: a case report and review of the literature.
Zhang Y; Wright C; Flores A
J Med Case Rep; 2018 Jul; 12(1):187. PubMed ID: 29960601
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients.
Wattjes MP; Wijburg MT; Vennegoor A; Witte BI; Roosendaal SD; Sanchez E; Liu Y; Martins Jarnalo CO; Richert ND; Uitdehaag BM; Barkhof F; Killestein J
Mult Scler; 2016 Aug; 22(9):1174-83. PubMed ID: 26564995
[TBL] [Abstract][Full Text] [Related]
18. Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy.
Dong-Si T; Gheuens S; Gangadharan A; Wenten M; Philip J; McIninch J; Datta S; Richert N; Bozic C; Bloomgren G; Richman S; Weber T; Clifford DB
J Neurovirol; 2015 Dec; 21(6):637-44. PubMed ID: 25771865
[TBL] [Abstract][Full Text] [Related]
19. The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy.
Wattjes MP; Richert ND; Killestein J; de Vos M; Sanchez E; Snaebjornsson P; Cadavid D; Barkhof F
Mult Scler; 2013 Dec; 19(14):1826-40. PubMed ID: 24192217
[TBL] [Abstract][Full Text] [Related]
20. Atypical Multiple Sclerosis Lesions or Progressive Multifocal Leukoencephalopathy Lesions: That Is the Question.
De Mercanti SF; Gned D; Matta M; Iudicello M; Franchin E; Clerico M
J Investig Med High Impact Case Rep; 2020; 8():2324709620939802. PubMed ID: 32646245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
